Athos Therapeutics
PrivateLast Round
Debt
Apr 17, 2026
Total Funding Raised
$54.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Athos Therapeutics operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Series B round in February 2024.
Athos Therapeutics is a biotechnology company that develops an artificial intelligence technology platform and therapeutics aimed at patients with inflammatory bowel and autoimmune diseases, utilizing machine learning to discover and develop personalized drug and gene targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Athos Therapeutics Comparables
Compare Athos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Auransa | 82% | |
| Prometheus Therapeutics Inc. | 81% | |
| Omic.ai | 79% |
For institutional investors. Book with your work email.
Athos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 17, 2026 | ||||
| Series B | Feb 16, 2024 | ||||
| Series A | Nov 15, 2021 | ||||
| Seed | Mar 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Raised $10.3M in a seed funding round.
- Mar 10, 2026
CEO to speak at The Montgomery Summit on March 10-11, 2026.
For institutional investors. Book with your work email.
Athos Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Athos Therapeutics's valuation, stock price, and market status.
Is Athos Therapeutics a public or private company?
Athos Therapeutics is a private company.
What is the current stock price of Athos Therapeutics?
Athos Therapeutics is a private company, so its shares have no public market price. Caplight tracks Athos Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Athos Therapeutics worth (valuation)?
Valuation information for Athos Therapeutics is not publicly available.
Can I buy Athos Therapeutics stock?
Athos Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Athos Therapeutics's last funding round?
Athos Therapeutics's most recent funding round was Debt on April 17, 2026.
Who are the main investors in Athos Therapeutics?
Investor information for Athos Therapeutics is not publicly disclosed.
Will Athos Therapeutics IPO soon?
No public IPO plans have been announced for Athos Therapeutics.
How can I track Athos Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Athos Therapeutics's shares on secondary markets.